To determine if RUNX1 hypermethylation may be a biomarker for the detection of NSCLC in other races, we tested RUNX1 hypermethylation in the 899 TCGA primary lung cancers (75 normal tissues and 824 tumor tissues). This evidence concerns the gene RUNX1 and neoplasm.